Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02949622
Other study ID # CAPES 5566-10-0
Secondary ID
Status Completed
Phase N/A
First received October 14, 2016
Last updated June 20, 2017
Start date February 2013
Est. completion date October 2016

Study information

Verified date June 2017
Source Universidad de Granada
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to identify the psychological, emotional and lifestyle variables that can have an influence on the different components of metabolic syndrome (MetS) and develop a program for change lifestyle in this patients.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date October 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

- Between 25 and 65 years age

- Waist circumference >88 cm for women and >102 cm for men

- Blood pressure: systolic = 130 mmHg and diastolic = 85 mmHg

- Fasting glucose level = 110mg/dL

- Triglycerides: = 150 mg/dL

- HDL cholesterol =40 mg/dL in men and =50 mg/DL in women

Exclusion Criteria:

- Osteoarthritis,

- Active inflammatory diseases,

- Severe psychiatric disorders and/or significant cognitive impairment assessed using the Mini-Mental State Examination.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Multimodal intervention program
The intervention is structured as follows: Review of previous session (20 min) Agenda and goals (5 min) Presentation of the topic to be worked (15 min) Training (60 min) Summary and feedback (15 min)
Other:
Lifestyle counseling
The group of lifestyle counseling will have basic guidelines, according to the recommendations of public health.

Locations

Country Name City State
Spain Jaqueline Garcia da Silva Granada

Sponsors (3)

Lead Sponsor Collaborator
Universidad de Granada Coordenação de Aperfeiçoamento de Pessoal de Nível Superior., University Hospital Virgen de las Nieves

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Other Mini Mental State Examination - MMSE To assess the initial mental state of the patient and possible cognitive deficits. 5 minutes
Other Mini International Neuropsychiatric Interview - MINI Brief diagnostic interview, compatible with the DSM-V and ICD-10 criteria was used to evaluate possible co-morbidities in the sample. 30 minutes
Other Height height (cm) 2 minutes
Primary Weight weight (Kg) 2 minutes
Primary Waist circumference (cm). Measured using a tape measure placed in a horizontal plane, located at the midpoint between the last rib and the iliac crest 2 minutes
Primary Blood pressure Taken according to the recommendations of the American Heart Association, and considering the mean of three readings, each separated by two minutes. 15 minutes
Primary Lipid profile lipid profile (HDL-C, total cholesterol, triglycerides) 3 minutes
Primary Glycemic profile (fasting glucose) glycemic profile (fasting glucose) 3 minutes
Secondary State-Trait Anger Expression Inventory-2 - STAXI-2 To determine diverse components of anger, such as experience, expression and control, as well as its facets such as state and trait, the Inventory of Expression of Anger State-Trait (STAXI-2) was used. It consists of 49 items organised in 6 scales and 5 subscales, permitting the attainment of an index for each scale and subscale, as well as a general index of the inventory. 5 minutes
Secondary Perceived Stress Scale -PSS To measure the perceived stress during the previous month, the Perceived Stress Scale was used, with a total of 14 items. 5 minutes
Secondary Assertiveness Inventory To evaluate the general assertiveness, the Assertiveness Inventory (AI) consisting of 30 items was used . 5 minutes
Secondary Medical Outcomes Study 12-Item Short Form - SF-12 To determine the health-related quality of life the Medical Outcomes Study 12-Item Short Form (SF-12), which is composed of two components related to physical and mental health, was used. 5 minutes
Secondary Mediterranean-diet scale To evaluate the level of adherence to the Mediterranean diet (MedDiet). Consisting of 14 items that evaluate whether foods are included that can prevent cardiovascular risk such as olive oil, fish, vegetables, fruits, cereals and also foods that can increase the chances of risk such as cold meats, trans fats and excess salt. The degree of adherence to the MedDiet is given by the sum of the items. A score below 11 is considered low adherence and higher than 11 as high. 5 minutes
Secondary Fagerström Test for Nicotine Dependence To evaluate the degree of physical dependence on nicotine. The test consists of six items with two or four response alternatives. The score ranges from 0 to 10. High scores in the FTND (6 or more) indicate a high degree of dependence. 5 minutes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02702375 - Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases N/A
Completed NCT02649348 - Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome N/A
Completed NCT02918422 - Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption N/A
Completed NCT02356952 - Effect of a Low Glycemic Index on Metabolic Syndrome N/A
Completed NCT02337933 - Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome Phase 2
Completed NCT02459691 - Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos) N/A
Completed NCT02402985 - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics N/A
Completed NCT01694056 - Soy Protein Intake and the Metabolic Syndrome N/A
Completed NCT00344903 - Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort N/A
Recruiting NCT00408824 - Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study) N/A
Completed NCT00362908 - Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome N/A
Completed NCT00395486 - ROMEO (Rosuvastatin in Metabolic syndrOme) Phase 4
Completed NCT00140816 - Dairy Products and Metabolic Effects (Norwegian Part) N/A
Completed NCT00166036 - Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells Phase 2
Completed NCT00455325 - Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) Phase 2
Completed NCT00101517 - Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease N/A
Recruiting NCT00177892 - Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress N/A
Completed NCT00073775 - Epidemiology of Stress and the Metabolic Syndrome N/A
Completed NCT00074451 - Genomewide Search for Loci Underlying Metabolic Syndrome
Completed NCT00200993 - Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) Phase 2